This competitive renewal application will continue to explore the role of IL-16 in CD4+ cell accumulation in human atopic asthma. In the previous grant period, the investigators found that IL-16 is the major lymphocyte chemoattractant released early after segmental airway antigen challenge; that the epithelium of atopic asthmatics preferentially expresses IL-16 mRNA and protein; and that the degree of epithelial expression of IL-16 correlates with the extent of CD4+ T cell accumulation and airway reactivity. They have recently observed that glucocorticoids inhibit IL-16 expression in epithelium and that IL-9, IL-13 and histamine induce IL-16 expression and secretion in human epithelial cells in vitro. The investigators propose that given IL-16's functions as a CD4+ T cell chemotactic factor, and its ability to inhibit T cell receptor mediated functions, it might function in the lung in asthma either as a pro-inflammatory or immuno-modulatory cytokine depending upon the type of local reaction. In this application, they hypothesize that airway epithelial IL-16 expression is up-regulated by Th2 cytokines and histamine and inhibited by glucocorticoids.
Their aims are to: 1) identify the IL-9, IL-13, histamine and glucocorticoid responsive regulatory elements in the IL-16 promoter; and 2) determine the factors responsible for epithelial cell secretion of IL-16.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI035680-10
Application #
6710631
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Dong, Gang
Project Start
1994-12-01
Project End
2005-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
10
Fiscal Year
2004
Total Cost
$366,750
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Croq, Francoise; Vizioli, Jacopo; Tuzova, Marina et al. (2010) A homologous form of human interleukin 16 is implicated in microglia recruitment following nervous system injury in leech Hirudo medicinalis. Glia 58:1649-62
Green, Daniel S; Center, David M; Cruikshank, William W (2009) Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy. J Virol 83:5765-72
Zhang, Yujun; Tuzova, Marina; Xiao, Zhi-Xiong J et al. (2008) Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. J Immunol 180:402-8
Mashikian, M V; Tarpy, R E; Saukkonen, J J et al. (1998) Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients. J Allergy Clin Immunol 101:786-92
Center, D M; Kornfeld, H; Cruikshank, W W (1996) Interleukin 16 and its function as a CD4 ligand. Immunol Today 17:476-81